Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Avnet

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Oncotarget|August 28, 2016
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistanceSofia Avnet, Silvia Lemma, Margherita Cortini, et al.
International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.
Oncotarget|September 15, 2017
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinomaGemma Di Pompo, Silvia Lemma, Lorenzo Canti, et al.
Expert Opinion on Therapeutic Targets|September 12, 2015
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatmentFrancesca Perut, Fabrizio Carta, Gloria Bonuccelli, et al.
Cancer Letters|July 2, 2026
Talazoparib engages innate immune activation via PARP trapping-dependent cGAS/STING activation in Ewing SarcomaMarianna Carrabotta, Maria Cristina Manara, Lorena Landuzzi, et al.
Biochimica Et Biophysica Acta|December 25, 2012
Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophyMarta Columbaro, Elisabetta Mattioli, Nadir M Maraldi, et al.
Cancers|January 20, 2021
Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic TargetMargherita Cortini, Andrea Armirotti, Marta Columbaro, et al.
Cancer Research|March 5, 2009
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcomaSofia Avnet, Laura Sciacca, Manuela Salerno, et al.
Biochimica Et Biophysica Acta|March 23, 2011
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclastsSofia Avnet, Rosanna Pallotta, Francesca Perut, et al.
Cancers|March 11, 2023
Behavioral Voluntary and Social Bioassays Enabling Identification of Complex and Sex-Dependent Pain-(-Related) Phenotypes in Rats with Bone CancerDaniel Segelcke, Jan Linnemann, Bruno Pradier, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Oncotarget|August 28, 2016
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistanceSofia Avnet, Silvia Lemma, Margherita Cortini, et al.
International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.
Oncotarget|September 15, 2017
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinomaGemma Di Pompo, Silvia Lemma, Lorenzo Canti, et al.
Expert Opinion on Therapeutic Targets|September 12, 2015
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatmentFrancesca Perut, Fabrizio Carta, Gloria Bonuccelli, et al.
Cancer Letters|July 2, 2026
Talazoparib engages innate immune activation via PARP trapping-dependent cGAS/STING activation in Ewing SarcomaMarianna Carrabotta, Maria Cristina Manara, Lorena Landuzzi, et al.
Biochimica Et Biophysica Acta|December 25, 2012
Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophyMarta Columbaro, Elisabetta Mattioli, Nadir M Maraldi, et al.
Cancers|January 20, 2021
Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic TargetMargherita Cortini, Andrea Armirotti, Marta Columbaro, et al.
Cancer Research|March 5, 2009
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcomaSofia Avnet, Laura Sciacca, Manuela Salerno, et al.
Biochimica Et Biophysica Acta|March 23, 2011
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclastsSofia Avnet, Rosanna Pallotta, Francesca Perut, et al.
Cancers|March 11, 2023
Behavioral Voluntary and Social Bioassays Enabling Identification of Complex and Sex-Dependent Pain-(-Related) Phenotypes in Rats with Bone CancerDaniel Segelcke, Jan Linnemann, Bruno Pradier, et al.
Pageof 11